Cargando…

Unique invariant CD8(+) T cell population persists in MS

Detalles Bibliográficos
Autores principales:	Sabatino, Joseph J., Zamvil, Scott S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529280/ https://www.ncbi.nlm.nih.gov/pubmed/26280013 http://dx.doi.org/10.1212/NXI.0000000000000140

Ejemplares similares

Aryl hydrocarbon receptor activity may serve as a surrogate marker for MS disease activity
por: Sabatino, Joseph J., et al.
Publicado: (2017)

Anti-CD20 therapy depletes activated myelin-specific CD8(+) T cells in multiple sclerosis
por: Sabatino, Joseph J., et al.
Publicado: (2019)

Can Systemic Anti-CD20 B Cell-Depleting Antibodies Eliminate Meningeal Follicles in Multiple Sclerosis?
por: Gupta, Sasha, et al.
Publicado: (2021)

Acute liver injury in a Glatopa-treated patient with MS
por: Sabatino, Joseph J., et al.
Publicado: (2017)

An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans
Publicado: (1994)

Conversion of the CD8 lineage to CD4 T cells
por: Guzman, Maria P., et al.
Publicado: (2015)

Antigen-delivery through invariant chain (CD74) boosts CD8 and CD4 T cell immunity
por: Mensali, Nadia, et al.
Publicado: (2019)

Requirements for CD1d Recognition by Human Invariant Vα24(+) CD4(−)CD8(−) T Cells
por: Exley, Mark, et al.
Publicado: (1997)

Distinct and Overlapping Effector Functions of Expanded Human CD4(+), CD8α(+) and CD4(-)CD8α(-) Invariant Natural Killer T Cells
por: O'Reilly, Vincent, et al.
Publicado: (2011)

Invariant NKT Cells Regulate the CD8 T Cell Response during Theiler's Virus Infection
por: Mars, Lennart T., et al.
Publicado: (2014)

CD4(+)/CD8(+) mucosa-associated invariant T cells foster the development of endometriosis: a pilot study
por: Li, Caihua, et al.
Publicado: (2019)

Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate
por: Spencer, Collin M., et al.
Publicado: (2015)

The Uniqueness of [Image: see text]-Matrix Graph Invariants
por: Dehmer, Matthias, et al.
Publicado: (2014)

Elderly CD8(+) T cells in the focus for immunotherapeutic approaches
por: Lis, Annette, et al.
Publicado: (2023)

Lymph-borne CD8α(+) dendritic cells are uniquely able to cross-prime CD8(+) T cells with antigen acquired from intestinal epithelial cells
por: Cerovic, V, et al.
Publicado: (2015)

Targeting B cells to modify MS, NMOSD, and MOGAD: Part 2
por: Graf, Jonas, et al.
Publicado: (2020)

Targeting B Cells to Modify MS, NMOSD, and MOGAD: Part 1
por: Graf, Jonas, et al.
Publicado: (2020)

Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity
por: Shinoda, Koji, et al.
Publicado: (2023)

Persistently reduced humoral and sustained cellular immune response from first to third SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients
por: Bajwa, Hamza Mahmood, et al.
Publicado: (2022)

Coaching tumor-infiltrating CD8(+) T cells to eat right
por: Kurupati, Ral, et al.
Publicado: (2018)

CD8(+) T Cells: Exacting a Toll in Viral Pneumonia
por: Ballinger, Megan N., et al.
Publicado: (2020)

Longitudinal adaptive immune responses following sequential SARS-CoV-2 vaccinations in MS patients on anti-CD20 therapies and sphingosine-1-phosphate receptor modulators
por: Sabatino, Joseph J., et al.
Publicado: (2023)

Avidity for antigen shapes clonal dominance in CD8(+) T cell populations specific for persistent DNA viruses
por: Price, David A., et al.
Publicado: (2005)

Deficiency of CD8(+) effector memory T cells is an early and persistent feature of multiple sclerosis
por: Pender, Michael P, et al.
Publicado: (2014)

Glatiramer acetate immune modulates B-cell antigen presentation in treatment of MS
por: Häusler, Darius, et al.
Publicado: (2020)

Thymoproteasomes produce unique peptide motifs for positive selection of CD8(+) T cells
por: Sasaki, Katsuhiro, et al.
Publicado: (2015)

Protective CD8(+) T cell memory without help
por: Fang, Min, et al.
Publicado: (2015)

A rare population of tumor antigen-specific CD4(+)CD8(+) double-positive αβ T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells
por: Matsuzaki, Junko, et al.
Publicado: (2019)

CD39 as a marker of pathogenic CD8+ T cells in cancer and other chronic inflammatory diseases
por: Canale, Fernando Pablo, et al.
Publicado: (2018)

Unique transcriptional profile of liver-resident memory CD8(+) T cells induced by immunization with malaria sporozoites
por: Tse, Sze-Wah, et al.
Publicado: (2013)

Mucosal-associated invariant T cells and oral microbiome in persistent apical periodontitis
por: Davanian, Haleh, et al.
Publicado: (2019)

The Role of Invariant Natural Killer T Cells in Dendritic Cell Licensing, Cross-Priming, and Memory CD8(+) T Cell Generation
por: Gottschalk, Catherine, et al.
Publicado: (2015)

Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS?
por: Weber, Martin S.
Publicado: (2015)

Breaching the Defenses? Mucosal-associated Invariant T Cells, Smoking, and Chronic Obstructive Pulmonary Disease
por: Staples, Karl J.
Publicado: (2022)

In vitro up-regulation of expression of GITR on human CD8+ cells
por: Thanavala, Yasmin
Publicado: (2009)

The pivotal role of CD8+ T cells in hepatitis E virus infection
por: Brüggemann, Yannick, et al.
Publicado: (2022)

Spleen-Resident CD4(+) and CD4(−) CD8α(−) Dendritic Cell Subsets Differ in Their Ability to Prime Invariant Natural Killer T Lymphocytes
por: Bialecki, Emilie, et al.
Publicado: (2011)

A CD8(+) NK cell transcriptomic signature associated with clinical outcome in relapsing remitting multiple sclerosis
por: McKinney, Eoin F., et al.
Publicado: (2021)

Psoriasis and the MAITing game: A role for IL-17A+ invariant TCR CD8+ T cells in psoriasis?
por: Johnston, Andrew, et al.
Publicado: (2014)

Involvement of impaired CD8(+) mucosal-associated invariant T cells and myeloid-derived suppressor cells in polycystic ovary syndrome
por: Zhu, Mengting, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lee4p4qktodikouo6358co2fbf